• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制剂变量对白蛋白从可生物降解微粒系统中的体外释放的影响。

Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.

作者信息

Igartua M, Hernández R M, Esquisabel A, Gascon A R, Calvo M B, Pedraz J L

机构信息

Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.

出版信息

J Microencapsul. 1997 May-Jun;14(3):349-56. doi: 10.3109/02652049709051138.

DOI:10.3109/02652049709051138
PMID:9147284
Abstract

Poly(D,L-lactide-co-glycolide) microspheres containing BSA were prepared by a modified solvent evaporation method using a double emulsion. These microspheres were characterized for size, morphology, surface absorbed protein, encapsulation efficiency and release kinetics. The influence of two formulation variables (the procedure to obtain the first emulsions and the lyophilization of the microspheres once obtained) on the physical characteristics and release behaviour of the microspheres was also investigated. Sonicated microspheres were smooth and spherical, with a mean particle size of 20 microns and an encapsulation efficiency of 81%. When the first emulsion was prepared by vortex mixing the particles were irregular and porous, with a mean size of 31 microns and a lower encapsulation efficiency (56%). The sonication allows a more homogeneous emulsion as well as a lower percentage of albumin adsorbed on the surface. The in vitro release profile was described as a biexponential process with an initial burst effect due to the release of the protein adsorbed on the microsphere surface and a second sustained release phase due to protein diffusion through the channels or pores formed in the polymer coat. The release of BSA was dependent on the preparation method. The greatest burst release was found for microspheres formulated using the vortex mixer, 58% of the encapsulated protein was released during the first 24 h, whereas sonicated microspheres released 32.2%. This burst effect could be reduced by lyophilizing the microspheres following their preparation. The amount of protein released decreased to 28.3% and 51.6% in sonicated and non-sonicated microspheres respectively, when they were lyophilized.

摘要

采用双乳液法,通过改进的溶剂蒸发法制备了含有牛血清白蛋白(BSA)的聚(D,L-丙交酯-共-乙交酯)微球。对这些微球的尺寸、形态、表面吸附蛋白、包封率和释放动力学进行了表征。还研究了两个配方变量(获得初乳的方法以及微球制备后冻干)对微球物理特性和释放行为的影响。超声处理的微球光滑呈球形,平均粒径为20微米,包封率为81%。当通过涡旋混合制备初乳时,颗粒不规则且多孔,平均尺寸为31微米,包封率较低(56%)。超声处理可使乳液更均匀,且表面吸附的白蛋白百分比更低。体外释放曲线被描述为双指数过程,由于微球表面吸附蛋白的释放而出现初始突释效应,以及由于蛋白通过聚合物包衣中形成的通道或孔隙扩散而出现第二个持续释放阶段。BSA的释放取决于制备方法。使用涡旋混合器制备的微球突释最大,在最初24小时内释放了58%的包封蛋白,而超声处理的微球释放了32.2%。制备后冻干微球可降低这种突释效应。超声处理和未超声处理的微球冻干后,蛋白释放量分别降至28.3%和51.6%。

相似文献

1
Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.制剂变量对白蛋白从可生物降解微粒系统中的体外释放的影响。
J Microencapsul. 1997 May-Jun;14(3):349-56. doi: 10.3109/02652049709051138.
2
Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.改变外部水相的pH值可能会调节通过水包油包水溶剂蒸发法制备的聚(丙交酯-乙交酯)微球中蛋白质的包封率和释放率。
J Microencapsul. 1998 Jul-Aug;15(4):421-30. doi: 10.3109/02652049809006869.
3
Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.工艺和配方参数对通过溶剂蒸发法制备的聚(d,l-丙交酯-共-乙交酯)微球的特性及内部形态的影响
Eur J Pharm Biopharm. 2008 Feb;68(2):214-23. doi: 10.1016/j.ejpb.2007.06.008. Epub 2007 Jun 15.
4
Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.硫酸特布他林载入PLGA(25/75)和L - PLA微球的制剂及其体外/体内评价
J Microencapsul. 2003 Mar-Apr;20(2):261-71.
5
Influence of shaking and surfactants on the release of bsa from plga microspheres.振荡和表面活性剂对牛血清白蛋白从聚乳酸-羟基乙酸共聚物微球中释放的影响。
Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):92-6. doi: 10.1007/BF03189321.
6
The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.制剂变量对采用油中油单相溶剂蒸发法制备的载胰岛素聚(乳酸-乙醇酸共聚物)微球特性的影响。
Colloids Surf B Biointerfaces. 2009 Nov 1;74(1):340-9. doi: 10.1016/j.colsurfb.2009.08.003. Epub 2009 Aug 12.
7
Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.采用油包油(o/o)溶剂蒸发法将卵清蛋白微囊化于聚(丙交酯-乙交酯)中。
J Microencapsul. 1996 Sep-Oct;13(5):509-18. doi: 10.3109/02652049609026036.
8
Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.后乳化干燥工艺对人血清白蛋白微囊化的影响。
Int J Pharm. 2006 Jan 3;307(1):16-22. doi: 10.1016/j.ijpharm.2005.09.026. Epub 2005 Nov 4.
9
Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.采用复乳/溶剂挥发技术制备载血管内皮生长因子(VEGF)聚(D,L-丙交酯-共-乙交酯)微球及其体外性质考察。
J Microencapsul. 2011;28(1):46-54. doi: 10.3109/02652048.2010.523795.
10
Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.用于肠胃外缓释的高乌甲素微球:制剂变量的影响及体外特性研究
Pharmazie. 2011 Sep;66(9):654-61.

引用本文的文献

1
Development of a local controlled release system for therapeutic proteins in the treatment of skeletal muscle injuries and diseases.开发局部控释系统治疗骨骼肌损伤和疾病的治疗性蛋白。
Cell Death Dis. 2024 Jul 2;15(7):470. doi: 10.1038/s41419-024-06645-2.
2
Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis.水飞蓟宾-壳聚糖纳米粒的绿色合成:一种新型纳米制剂,具有增强的抗肝纤维化作用。
Int J Mol Sci. 2022 May 12;23(10):5420. doi: 10.3390/ijms23105420.
3
Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases.
脑源性神经营养因子(GDNF)和牛磺熊去氧胆酸(TUDCA)共载聚乳酸-羟基乙酸共聚物微球的制备及其用于治疗视网膜疾病的可能性。
Drug Deliv Transl Res. 2021 Apr;11(2):566-580. doi: 10.1007/s13346-021-00930-9. Epub 2021 Feb 27.
4
Controlled Release of Lysozyme from Double-Walled Poly(Lactide-Co-Glycolide) (PLGA) Microspheres.溶菌酶从双层聚(丙交酯-共-乙交酯)(PLGA)微球中的控释。
Polymers (Basel). 2017 Oct 3;9(10):485. doi: 10.3390/polym9100485.
5
Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.载胰岛素双壁聚(丙交酯-共-乙交酯)微球的制备、表征及体外释放研究
Drug Deliv Transl Res. 2016 Jun;6(3):308-18. doi: 10.1007/s13346-016-0278-y.
6
Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery.载药微球的双重乳液技术及其在控制释放中的应用前景。
Saudi Pharm J. 2013 Apr;21(2):125-41. doi: 10.1016/j.jsps.2012.05.009. Epub 2012 May 26.
7
Highly loaded, sustained-release microparticles of curcumin for chemoprevention.高载量、持续释放的姜黄素微球用于化学预防。
J Pharm Sci. 2011 Jul;100(7):2599-609. doi: 10.1002/jps.22475. Epub 2011 Jan 14.
8
Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.载胰岛素聚(丙烯酰羟乙基淀粉)-聚乳酸-羟基乙酸共聚物复合微球的制备及体内外评价
Pharm Res. 2003 Mar;20(3):452-9. doi: 10.1023/a:1022668507748.
9
A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres.一种用于评估蛋白质从PLGA微球释放后生物完整性的新型体外递送系统。
Pharm Res. 2002 Jul;19(7):1046-51. doi: 10.1023/a:1016482809810.
10
Lysozyme stability in primary emulsion for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients.用于制备PLGA微球的初乳中溶菌酶的稳定性:回收方法和稳定辅料的影响
Pharm Res. 2002 May;19(5):629-33. doi: 10.1023/a:1015354028908.